Healthcare AI Acquisition Corp. Class A Ordinary Shares
HAIA
HAIA was delisted on the 16th of December, 2024.
42 hedge funds and large institutions have $126M invested in Healthcare AI Acquisition Corp. Class A Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$15.9M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$9.89M |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$9.45M |
| 4 |
Citigroup
New York
|
+$6.64M |
| 5 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$6.36M |
Top Sellers
HAIA Hedge Fund Activity: Q1 2022 in Review
42 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Healthcare AI Acquisition Corp. Class A Ordinary Shares (HAIA) for Q1 2022, worth a combined $126M.
Buyers outnumbered sellers: 42 funds opened new HAIA positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Saba Capital Management, opening a new position worth an estimated $15.9M.
- 42 institutional investors held Healthcare AI Acquisition Corp. Class A Ordinary Shares (HAIA) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $126M of Healthcare AI Acquisition Corp. Class A Ordinary Shares stock for Q1 2022.
- 42 funds opened new Healthcare AI Acquisition Corp. Class A Ordinary Shares positions in Q1 2022 and 0 closed out, a net change of +42 holders.
- The largest Healthcare AI Acquisition Corp. Class A Ordinary Shares buyer in Q1 2022 was Saba Capital Management, an estimated $15.9M added.
Based on aggregated 13F filings for Q1 2022.